Actively Recruiting
Prehabilitation in Gynaecological Cancer Patients
Led by Charles University, Czech Republic · Updated on 2026-03-19
64
Participants Needed
1
Research Sites
283 weeks
Total Duration
On this page
Sponsors
C
Charles University, Czech Republic
Lead Sponsor
U
University Hospital Ostrava
Collaborating Sponsor
AI-Summary
What this Trial Is About
Prehabilitation refers to interventions aiming to improve patients' resilience and functional capacity before a known stressful event, e.g., scheduled surgery. These interventions usually consist of physical activity and psychological and nutritional support. There is substantial evidence of the positive effect of multimodal prehabilitation among patients treated surgically for non-gynaecological cancers; however, no prospective data are available in gynaecological cancer patients. PHOCUS trial is a prospective randomised trial aiming to evaluate the role of multimodal prehabilitation in patients with gynaecological cancer. Sixty-four patients will be randomised in single institution within 36 months with a 1:1 ratio into ARM A: control arm which will be provided with a basic information and standard of care support; ARM B: active arm undergoing multimodal prehabilitation composed of physical activity and psychological and nutritional support. All patients will be assessed at standard intervals (three times during the trial) by a spectrum of non-invasive tests, evaluating physical functional capacity, postoperative morbidity, nutritional status, level of stress and anxiety, and quality of life.
CONDITIONS
Official Title
Prehabilitation in Gynaecological Cancer Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female patients with epithelial ovarian cancer referred for neoadjuvant chemotherapy who meet all: FIGO stage III or IV; not candidates for primary debulking surgery; suitable for combined chemotherapy; candidates for interval debulking surgery
- Female patients with stage I or II endometrial cancer classified as frail by modified Frailty Index
- Endometrial cancer patients suitable for hormonal therapy
- Patients planned for postponed surgical treatment
You will not qualify if you...
- Presence of a second malignant tumor currently under treatment
- Patients not suitable for any surgery delay
- Patients physically unable to follow the prehabilitation plan or unable to walk
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Gynecologic Oncology Center in Prague
Prague, Czechia, 12000
Actively Recruiting
Research Team
J
Jana Stribrna
CONTACT
S
Stefan Lednicky, MD.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here